Profile
| Metric | Value |
|---|---|
| Full Name | CONMED Corporation |
| Ticker | NYSE: CNMD |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | conmed.com |
| Employees | 3,900 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $43.96 | |
| Price, 1D Change | +1.29% | |
| Market Cap | $1B | |
| TTM Dividend Yield | 1.36% | |
| PE Ratio | 21.35 | |
| Beta | 0.93 | |
| Revenue | $1B | |
| Revenue, 1Y Change | +4.98% | |
| EPS | $4.25 | |
| EPS, 1Y Change | +108.06% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.20 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 3:2 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $4.25 | |
| EPS Estimate | $4.50 | |
| EPS Est. Change | +5.88% | |
| Revenue | $1.30B | |
| Revenue Estimate | $1.37B | |
| Revenue Est. Change | +5.05% | |
| Current Price | $43.96 | |
| Price Target | - | $51.00 |
| Price Tgt. Change | - | +16.01% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $3.50 | $2.04 | -41.62% | |
| $4.03 | $4.25 | +5.58% | |
| $4.50 | N/A | +5.88% | |
| $4.46 | N/A | +4.99% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.25B | $1.24B | -0.72% | |
| $1.30B | $1.30B | +0.05% | |
| $1.37B | N/A | +5.05% | |
| $1.38B | N/A | +5.74% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -36.07% | |
| Price, 3Y | -52.94% | |
| Market Cap, 1Y | -35.93% | |
| Market Cap, 3Y | -52.20% | |
| Revenue, 1Y | +4.98% | |
| Revenue, 3Y | +28.21% | |
| EPS, 1Y | +108.06% | |
| EPS, 3Y | +118.98% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $43.96 | |
| SMA 200 | $50.17 | |
| SMA 200 vs Price | +14.12% | |
| SMA 50 | $42.42 | |
| SMA 50 vs Price | -3.50% | |
| Beta | 0.93 | |
| ATR | $1.49 | |
| 14-Day RSI | 60.08 | |
| 10-Day Volatility | 28.87% | |
| 1-Year Volatility | 43.78% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.20 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 1.82% | |
| Total Dividend | $0.80 | |
| Dividends Paid | $24.65M | |
| Payout Ratio | 18.62% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $1.30B | |
| EPS | $4.25 | |
| Gross Profit | $733.03M | |
| Gross Margin | 56.08% | |
| Operating Profit | $200.33M | |
| Operating Margin | 15.33% | |
| Net Income | $132.42M | |
| Net Margin | 10.13% | |
| EBITDA | $200.33M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.94 | |
| Current Ratio | 2.30 | |
| Quick Ratio | 1.05 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 1.99 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 21.35 | |
| PS Ratio | 1.01 | |
| PB Ratio | 1.35 | |
| EV/EBITDA | 11.64 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $962.68M | |
| Cash & Equivalents | $24.46M | |
| Total Assets | $2.31B | |
| Current Assets | $640.01M | |
| Total Liabilities | $1.34B | |
| Current Liabilities | $278.13M | |
| Total Debt | $947.16M | |
| Short Term Debt | $8.81M | |
| Accounts Payable | $102.25M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.11B | |
| Operating Expenses | $532.71M | |
| Cost Of Goods Sold | $573.98M | |
| SG&A | $478.28M | |
| D&A | $71.86M | |
| Interest Expense | $0.00 | |
| Income Tax | $30.61M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $166.97M | |
| CFI | -$13.08M | |
| CFF | -$151.00M | |
| Capex | $13.08M | |
| Free Cash Flow | $153.88M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| B of A Securities | → | |
| Wells Fargo | → | |
| Piper Sandler | → | |
| JP Morgan | → | |
| Piper Sandler | → | |
| Needham | → | |
| Wells Fargo | → | |
| Needham | → | |
| JP Morgan | → | |
| Stifel | → |
Analyst sentiment
Institutional ownership
Screeners with CNMD
Data Sources & References
- CNMD Official Website www.conmed.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/816956/000081695625000056/0000816956-25-000056-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/816956/000081695625000004/0000816956-25-000004-index.htm
- CNMD Profile on Yahoo Finance finance.yahoo.com/quote/CNMD
- CNMD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cnmd
FAQ
What is the ticker symbol for CONMED Corporation?
The ticker symbol for CONMED Corporation is NYSE:CNMD
Does CONMED Corporation pay dividends?
Yes, CONMED Corporation pays dividends. The last payment was $0.20, with an ex-dividend date on September 15, 2025
What sector is CONMED Corporation in?
CONMED Corporation is in the Healthcare sector
What industry is CONMED Corporation in?
CONMED Corporation is in the Medical Devices industry
What country is CONMED Corporation based in?
CONMED Corporation is headquartered in United States
When did CONMED Corporation go public?
CONMED Corporation initial public offering (IPO) was on July 23, 1987
Is CONMED Corporation in the S&P 500?
No, CONMED Corporation is not included in the S&P 500 index
Is CONMED Corporation in the NASDAQ 100?
No, CONMED Corporation is not included in the NASDAQ 100 index
Is CONMED Corporation in the Dow Jones?
No, CONMED Corporation is not included in the Dow Jones index
When was CONMED Corporation last earnings report?
CONMED Corporation's most recent earnings report was on November 5, 2025
When does CONMED Corporation report earnings?
The next expected earnings date for CONMED Corporation is January 28, 2026